2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II

Clinical trial NCT03941769 · COMPLETED

Trial details

NCT number: NCT03941769
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Cord Blood Transplant Recipient Myelodysplastic Syndrome Myeloproliferative Neoplasm

Start date: 2020-09-29
Primary completion: 2023-03-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.